U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07856641) titled 'Circadian Variation of Anti-Factor Xa in Hospitalized Trauma Patients' on Sept. 28.
Brief Summary: The purpose of this study is to determine whether a circadian rhythm exists in anti-FXa levels and AT3 activity in hospitalized trauma patients receiving low-molecular-weight heparin (LMWH) chemoprophylaxis
Study Start Date: Aug. 26
Study Type: OBSERVATIONAL
Condition:
Circadian Variation in Anti-Factor Xa (Anti-FXa) Activity
Recruitment Status: RECRUITING
Sponsor: The University of Texas Health Science Center, Houston
Information provided by (Responsible Party): Evaline Kihara, The University of Texas Health Science Center, Hous...